Glibenclamida no tratamento do diabete melito gestacional em estudo comparado à insulina

Silva, Jean C; Bertini, Anna M; Taborda, Wladimir; Becker, Felipe; Bebber, Fernanda R. L; Aquim, Gabriela M. D. C; Viesi, Juliana M. Z.
Arq. bras. endocrinol. metab ; 51(4): 541-546, jun. 2007. tab
Artículo en Portugués | LILACS | ID: lil-457090

Documentos relacionados

  1. Can glyburide be advocated over subcutaneous insulin for perinatal outcomes of women with gestational diabetes? A systematic review and meta-analysis.
  2. Oral Agents for the Treatment of Gestational Diabetes.
  3. Metformin is comparable to insulin for pharmacotherapy in gestational diabetes mellitus: A network meta-analysis evaluating 6046 women.
  4. Pharmacological Management of Gestational Diabetes Mellitus.
  5. The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy.
  6. Pharmacological therapy in gestational diabetes - a comparison between insulin and oral therapy.
  7. Effects of metformin and insulin on gestational diabetes mellitus: A dual drugs therapy approach.
  8. Comparative impact of pharmacological treatments for gestational diabetes on neonatal anthropometry independent of maternal glycaemic control: A systematic review and meta-analysis.
  9. Pharmacological treatment of gestational diabetes mellitus: point/counterpoint.
  10. Comparison of the therapeutic effects of metformin and glibenclamide on patients with gestational diabetes.